BRPI0614031A2 - manufacture, production, preparation and processing of a mixture of different combinations of anhydrous or aqueous volumes or in any molar amounts or volumes of the following soluble salts - Google Patents
manufacture, production, preparation and processing of a mixture of different combinations of anhydrous or aqueous volumes or in any molar amounts or volumes of the following soluble salts Download PDFInfo
- Publication number
- BRPI0614031A2 BRPI0614031A2 BRPI0614031-9A BRPI0614031A BRPI0614031A2 BR PI0614031 A2 BRPI0614031 A2 BR PI0614031A2 BR PI0614031 A BRPI0614031 A BR PI0614031A BR PI0614031 A2 BRPI0614031 A2 BR PI0614031A2
- Authority
- BR
- Brazil
- Prior art keywords
- added
- combination
- entries
- effective
- salts
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 238000012545 processing Methods 0.000 title claims abstract description 5
- 230000002308 calcification Effects 0.000 claims abstract description 8
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims abstract description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 4
- 241001465754 Metazoa Species 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 13
- 229910052783 alkali metal Inorganic materials 0.000 claims description 9
- 210000001519 tissue Anatomy 0.000 claims description 9
- 150000003863 ammonium salts Chemical class 0.000 claims description 7
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 6
- 150000001340 alkali metals Chemical class 0.000 claims description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims description 6
- 206010029148 Nephrolithiasis Diseases 0.000 claims description 5
- 210000000232 gallbladder Anatomy 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 206010003119 arrhythmia Diseases 0.000 claims description 4
- 206010015037 epilepsy Diseases 0.000 claims description 4
- 230000002440 hepatic effect Effects 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- 208000020084 Bone disease Diseases 0.000 claims description 3
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 claims description 3
- 206010010904 Convulsion Diseases 0.000 claims description 3
- 229910002651 NO3 Inorganic materials 0.000 claims description 3
- -1 alkali metal salts Chemical class 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 claims description 3
- 229940005989 chlorate ion Drugs 0.000 claims description 3
- 229910001914 chlorine tetroxide Inorganic materials 0.000 claims description 3
- TVWHTOUAJSGEKT-UHFFFAOYSA-N chlorine trioxide Chemical compound [O]Cl(=O)=O TVWHTOUAJSGEKT-UHFFFAOYSA-N 0.000 claims description 3
- 210000004087 cornea Anatomy 0.000 claims description 3
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 claims description 3
- 150000004694 iodide salts Chemical class 0.000 claims description 3
- 210000000653 nervous system Anatomy 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
- 229910052977 alkali metal sulfide Inorganic materials 0.000 claims description 2
- 201000001883 cholelithiasis Diseases 0.000 claims description 2
- 230000036461 convulsion Effects 0.000 claims description 2
- 208000001130 gallstones Diseases 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical class 0.000 claims description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract description 6
- 239000011591 potassium Substances 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000001394 metastastic effect Effects 0.000 abstract description 2
- 206010061289 metastatic neoplasm Diseases 0.000 abstract description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 4
- 159000000007 calcium salts Chemical class 0.000 abstract 4
- 229910052700 potassium Inorganic materials 0.000 abstract 4
- 239000011734 sodium Substances 0.000 abstract 4
- 229910052708 sodium Inorganic materials 0.000 abstract 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- 239000011593 sulfur Substances 0.000 abstract 3
- 238000004090 dissolution Methods 0.000 abstract 2
- 150000002823 nitrates Chemical class 0.000 abstract 2
- 239000011435 rock Substances 0.000 abstract 2
- 229940043430 calcium compound Drugs 0.000 abstract 1
- 150000001674 calcium compounds Chemical class 0.000 abstract 1
- 239000003086 colorant Substances 0.000 abstract 1
- 150000003463 sulfur Chemical class 0.000 abstract 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910001424 calcium ion Inorganic materials 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000003599 detergent Substances 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 208000000913 Kidney Calculi Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- KWKXNDCHNDYVRT-UHFFFAOYSA-N dodecylbenzene Chemical class CCCCCCCCCCCCC1=CC=CC=C1 KWKXNDCHNDYVRT-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 210000003499 exocrine gland Anatomy 0.000 description 1
- 238000009212 extracorporeal shock wave lithotripsy Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 229910001463 metal phosphate Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003348 petrochemical agent Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/835—Mixtures of non-ionic with cationic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/86—Mixtures of anionic, cationic, and non-ionic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/02—Inorganic compounds ; Elemental compounds
- C11D3/04—Water-soluble compounds
- C11D3/046—Salts
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/02—Inorganic compounds
- C11D7/04—Water-soluble compounds
- C11D7/10—Salts
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/268—Carbohydrates or derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Insects & Arthropods (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Animal Husbandry (AREA)
- Neurology (AREA)
Abstract
FABRICAçáO, PRODUçAO, PREPARO E PROCESSAMENTO DE UMA MISTURA DE DIFERENTES COMBINAçõES DE VOLUMES ANIDROS OU AQUOSOS OU EM QUAISQUER QUANTIDADES OU VOLUME MOLARES DO SEGUINTES SAIS SOLUVEIS Calcificação metastática e formação de rocha é produzida com produção de sais de cálcio insolúveis como oxalato de cálcio ou outros sais insolúveis. Usando uma mistura de cloreto, sulfatos e nitratos de potássio, sódio e enxofre poderia resultar na formação de compostos de cálcio solúveis e sais de potássio, sódio e enxofre e dissolução de calcificação e/ou rochas formadas já existentes. Manchas e algumas cores são sais precipitados, usando uma mistura de cloretos1 sulfatos e nitratos de potássio, sódio e enxofre poderia resultar na formação de compostos solúveis de sais de potássio, sódio e enxofre e dissolução de manchas já existentes.MANUFACTURE, PRODUCTION, PREPARATION AND PROCESSING OF A MIXTURE OF DIFFERENT COMBINATIONS OF ANYTHING OR AQUEOUS VOLUMES OR IN ANY QUANTITIES OR MOLAR VOLUME OF THE FOLLOWING SOLUBLE SALTS Metastatic calcification and rock formation is produced with production of insoluble calcium salts or other insoluble calcium salts such as calcium salts or insoluble calcium salts. insoluble salts. Using a mixture of chloride, sulfates and nitrates of potassium, sodium and sulfur could result in the formation of soluble calcium compounds and salts of potassium, sodium and sulfur and dissolution of existing calcification and / or formed rocks. Stains and some colors are precipitated salts, using a mixture of potassium, sodium and sulfur chlorides1 sulfates and nitrates could result in the formation of soluble compounds of potassium, sodium and sulfur salts and dissolution of existing stains.
Description
FABRICAÇÃO, PRODUÇÃO, PREPARO E PROCESSAMENTO DE UMAMISTURA DE DIFERENTES COMBINAÇÕES DE VOLUMES ANIDROS OUAQUOSOS OU EM QUAISQUER QUANTIDADES OU VOLUME MOLARES DOSMANUFACTURING, PRODUCTION, PREPARATION AND PROCESSING OF A MIXTURE OF DIFFERENT COMBINATIONS OF EASY VOLUME OR AT ANY MOLAR QUANTITIES OR VOLUME
SEGUINTES SAIS SOLÚVEISNEXT SOLUBLE SALTS
CAMPO TÉCNICOTECHNICAL FIELD
1. Medicina1. Medicine
2. Química2. Chemistry
FUNDAMENTO DA TÉCNICATECHNICAL BACKGROUND
Detergentes são formados de compostos de superfície osquais não são ambientalmente seguros. Eles são ou naturaisou sintéticos. Detergentes solúveis em óleo são usados emgasolina e óleos lubrificantes para manter impurezasparticuladas em suspensão. Entre os detergentes solúveis emágua, álcoois e sabões comuns são eficazes. Ainda maisentão são os tipos sintéticos (sindetos) tais comododecilbenzeno sulfonado e alquilatos similares. Ossulfonatos de alquila linear (LAS) são mais biodegradáveisdo que são os do tipo de cadeia ramificada; eles são feitosde petroquímicos por varias técnicas de craqueamento epolimerização. Três tipos gerais de detergentes estão emuso; aniônico, catiônico e não iônico.Detergents are formed from surface compounds which are not environmentally safe. They are either natural or synthetic. Oil-soluble detergents are used in gasoline and lubricating oils to keep particulate impurities in suspension. Among the water-soluble detergents, alcohols and common soaps are effective. Even more so are synthetic types (syndromes) such as sulfonated dodecylbenzene and similar alkylates. Linear alkyl sulfonates (LAS) are more biodegradable than those of the branched chain type; They are made of petrochemicals by various cracking and polymerization techniques. Three general types of detergents are in use; anionic, cationic and nonionic.
Para superar cálculos ou calcificação metastática dotecido se desenvolvendo em vários sistemas de dutos docorpo humano como cálculos renais ou cálculos biliares,litotripsia extracorpórea por ondas de choque é usada, oucirurgicamente, ou remédios para mudar pH da urina paraevitar posteriormente formação de cálculo.To overcome endoscopic calculations or metastatic calcification developing in various human body duct systems such as kidney stones or gallstones, extracorporeal shock wave lithotripsy is used, or surgically, or urine pH-changing remedies to subsequently prevent stone formation.
Cálcio é essencial para células humanas e animais ondeele é essencial como uma parte integral do mineral ósseo,uma parte integral da parede da célula e sua funçãobiológica, a ligação essencial entre extração e contraçãoem todas as formas do músculo, a ligação essencial entreexcitação e secreção em ambas as glândulas endócrinas eexócrinas e um ativador, regulador e inibidor de enzimaschave.Calcium is essential for human and animal cells where it is essential as an integral part of bone mineral, an integral part of the cell wall and its biological function, the essential link between extraction and contraction in all forms of muscle, the essential link between arousal and secretion. both endocrine and exocrine glands and a key enzyme activator, regulator and inhibitor.
Glicose é essencial para absorção de outros solutos.Dependendo do transporte do soluto por convecção, apreparação de qualquer das misturas descritas nessa patenteinclui glicose ou um carboidrato em diferentes proporções.Glucose is essential for absorption of other solutes. Depending on the transport of the solute by convection, preparation of any of the mixtures described in this patent includes glucose or a carbohydrate in different proportions.
REVELAÇÃO DA INVENÇÃODISCLOSURE OF INVENTION
Regras de solubilidade incluem: -todos sais dos metaisalcalinos são solúveis; -todos sais do Ion amônio NH4+ sãosolúveis; -todos sais do íon nitrato (NO3") são solúveis,-todos sais do íon clorato (ClO3") são solúveis; - todossais do íon perclorato (ClO4") são solúveis; -todos sais doíon acetato (C2H3O2") são solúveis, -todos cloreto, brometose iodetos (exceto Ag+, Pb+ e Hg22+) são solúveis; -todossulfatos (SO42") (exceto aqueles de Ca+2, Sr+2, Ba+2 e Pb+)são solúveis;Solubility rules include: -all alkali metal salts are soluble; - all salts of NH4 + Ion ammonium are soluble; - all salts of the nitrate ion (NO3 ") are soluble; - all salts of the chlorate ion (ClO3") are soluble; - all salts of the perchlorate ion (ClO4 ") are soluble; - all salts of the acetate ion (C2H3O2") are soluble; - all chloride, bromose iodides (except Ag +, Pb + and Hg22 +) are soluble; - all sulfates (SO42 ") (except those of Ca + 2, Sr + 2, Ba + 2 and Pb +) are soluble;
-todos óxidos de metal são insolúveis, exceto aquelesde metais alcalinos, Ca+2, Sr+2, Ba+2,-all metal oxides are insoluble except those of alkali metals, Ca + 2, Sr + 2, Ba + 2,
-todos carbonatos (CO32") são insolúveis, excetoaqueles de metais alcalinos, e sais de amônio;all carbonates (CO32 ") are insoluble except for those of alkali metals and ammonium salts;
- todos fosfatos (PO43") são insolúveis, exceto aquelesde metais alcalinos, e sais de amônio (NH4+) ;- all phosphates (PO43 ") are insoluble except those of alkali metals and ammonium salts (NH4 +);
-todos sulfetos (S2") são insolúveis, exceto aquelesde metais alcalinos, e sais de amônio.- All sulfides (S2 ") are insoluble except those of alkali metals and ammonium salts.
ADÉIA NOVANew Postponement
Usando uma mistura de diferentes ou quaisquercombinações de volumes aquosos ou anidros ou molares dessessais solúveis é capaz de:Using a mixture of different or any combination of aqueous or anhydrous soluble desessal or molar volumes you are able to:
1. Remover mancha.1. Remove stain.
2. funcionar como um solvente geral para qualquerpropósito.2. function as a general solvent for any purpose.
3. funcionar como um solvente geral para calcificação dotecido humano ou animal.3. function as a general solvent for human or animal endowed calcification.
4. funcionar como um solvente geral para cálculo do tecidohumano ou animal em qualquer sistema como cálculo renal,cálculo no fígado, na vesícula biliar, etc.4. function as a general solvent for calculating human or animal tissue in any system such as renal calculus, liver, gallbladder, etc.
5. liberar íons cálcio solúveis em condições médicas deconvulsões e epilepsia de qualquer etiologia.5. release soluble calcium ions under medical conditions of convulsions and epilepsy of any etiology.
6. liberar íons potássio e sódio solúveis em condiçõesmédicas de convulsões e epilepsia de qualquer etiologia.6. release soluble potassium and sodium ions under medical conditions of seizures and epilepsy of any etiology.
7. liberar íons cálcio solúveis em condições médicas deosteoporoses de qualquer etiologia.7. release soluble calcium ions under deosteoporosis medical conditions of any etiology.
8. liberar íons cálcio em condições médicas de reabsorçãoóssea de qualquer etiologia.8. release calcium ions under medical conditions of bone resorption of any etiology.
9. liberar íons cálcio solúveis em condições médicas dedoença óssea de qualquer etiologia.9. release soluble calcium ions in medical conditions bone disease of any etiology.
10. liberar íons cálcio solúveis em condições médicas dearritmias cardíacas de qualquer etiologia.10. release soluble calcium ions in medical conditions of cardiac arrhythmias of any etiology.
11. liberar íon potássio e sódio solúveis em condiçõesmédicas de arritmias cardíacas de qualquer etiologia.11. release soluble potassium and sodium ion under medical conditions of cardiac arrhythmias of any etiology.
12. liberar íons solúveis em condições médicas de perda detransparência das lentes dos olhos, córnea, corpo vítreo ouaquoso ou perda de transparência de qualquer componente doolho de qualquer etiologia.12. release soluble ions under medical conditions of loss of transparency of the lens of the eye, cornea, vitreous or watery body or loss of transparency of any eye component of any etiology.
13. liberar íons solúveis em condições médicas associadascom desenvolvimento de placas de ateroma em qualquer lugardo corpo humano ou animal de qualquer etiologia.14. liberar íons solúveis em condições médicas associadascom desenvolvimento de placas no sistema nervoso emqualquer lugar do corpo humano ou animal de qualqueretiologia.13. release soluble ions in medical conditions associated with the development of atheromatous plaques anywhere in the human or animal body of any etiology.14. release soluble ions in medical conditions associated with the development of nervous system plaques anywhere in the human or animal body of any etiology.
15. liberar íons solúveis em condições médicas associadascom falhas na condução do impulso em qualquer lugar docorpo humano ou animal de qualquer etiologia.15. release soluble ions in medical conditions associated with failure to conduct the pulse anywhere in the human or animal body of any etiology.
16. fornecer oxidação de aldoses para ácido urônico esubseqüente glicuronização de todas substâncias necessáriaspara glicuronização hepática.16. provide aldoses oxidation to subsequent uronic acid glycuronization of all substances necessary for hepatic glucuronization.
DESCRIÇÃO DETALHADA DA PATENTE DEPOSITADADETAILED DESCRIPTION OF PATENT DEPOSITED
Fabricação, produção, preparo e processamento de umamistura de diferentes combinações de volumes anidros ouaquosos ou molares dos seguintes sais solúveis:Manufacture, production, preparation and processing of a mixture of different combinations of anhydrous or aqueous or molar volumes of the following soluble salts:
a- todos sais dos metais alcalinos,a- all alkali metal salts,
b- todos sais do íon amônio NH,b- all salts of the NH ammonium ion,
c- todos sais do íon nitrato (NO3") ,c- all salts of the nitrate ion (NO3 "),
d- todos sais do íon clorato (ClO3") ,d- all salts of the chlorate ion (ClO3 "),
e- todos sais do íon perclorato (ClO4") ,e- all salts of the perchlorate ion (ClO4 "),
f- todos sais do íon acetato (C2H3O2") ,f- all salts of the acetate ion (C2H3O2 "),
g- todos cloreto, brometo, e iodetos (exceto Ag+, Pb+ e Hg22+) ,g- all chloride, bromide, and iodides (except Ag +, Pb + and Hg22 +),
h- todos sulfatos (SO4"2) (exceto aqueles de Ca+2, Sr+2, Ba+2 e Pb+) ,h- all sulphates (SO4 "2) (except those of Ca + 2, Sr + 2, Ba + 2 and Pb +),
i- óxidos de metais alcalinos, Ca+2, Sr+2, Ba+2 emanganês,alkali metal oxides, Ca + 2, Sr + 2, Ba + 2 emanganese,
j- carbonatos (CO3"2) de metais alcalinos e sais deamônio,j- carbonates (CO3 "2) of alkali metals and deamonium salts,
k- fosfatos (PO4 3) de metais alcalinos, e sais de amônio(NH4+) ,l- Sulfetos (S2") de metais alcalinos, e sais de amônio,k- alkaline metal phosphates (PO4 3), and ammonium salts (NH4 +), l- alkali metal sulfides (S2 "), and ammonium salts,
m- Qualquer um ou todos e qualquer combinação decarboidratos,m- Any or all and any combination of carbohydrates,
n- Qualquer e todos tipos de mel natural.n- Any and all types of natural honey.
Onde:Where:
i. Todos de "a", "b", "c", "d", "e", "f , "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f", "g", "h", "i", "j", "k", e "L"adicionados a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", como um removedor demancha geral.i. All of "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "are effective if used as "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and " L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n "as a general spot remover.
ii. Todos de "a", "b", "c", "d"5 "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", Me", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", como um solvente geralpara qualquer propósito.ii. All from "a", "b", "c", "d" 5 "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", Me "," f, "g", "h", "i", "j", "k", and "L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n "as a general solvent for any purpose.
iii. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b",»c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", como um solvente geralpara evitar calcificação do tecido humano ou animal.iii. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n "as a general solvent to prevent calcification of human or animal tissue.
iv. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", como um solvente geralpara evitar cálculo do tecido humano ou animal em qualquersistema de cálculo renal, cálculo no fígado, na vesículabiliar, etc.iv. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n "as a general solvent to avoid calculation of human or animal tissue in any renal stone, liver, gallbladder, etc.
v. Todos de "a", "b", "c", "d", "e", "f", "g", "h"," i", "j", "k", e "L" são eficazes se usados como "a", "b",»c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a 11L"adicionado a "m" ou "n" ou "m+n", como um solvente geralpara calcificação do tecido humano ou animal.v. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to 11L" added to "m" or "n" or "m + n" as a general solvent for calcification of human or animal tissue.
vi. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", como um solvente geralpara cálculo do tecido humano ou animal em qualquer sistemacomo cálculo renal, cálculo no fígado, na vesícula biliaretc.saw. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n "as a general solvent for calculating human or animal tissue in any system such as renal calculus, calculus in the liver, gallbladder, etc.
vii. Todos de "a", "b", "c", "d" "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n" , em condições médicas deconvulsões e epilepsia de qualquer etiologia.vii. All of "a", "b", "c", "d" "e", "f", "g", "h", "i", "j", "k", and "L" are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n ", under conditions medical deconvulsions and epilepsy of any etiology.
viii. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", em condições médicas deosteoporose de qualquer etiologia.viii. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n ", in deosteoporosis medical conditions of any etiology.
ix. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", em condições médicas dereabsorção óssea de qualquer etiologia.ix. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n ", in bone-absorbing medical conditions of any etiology.
x. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i" , "j", "k", e "L" são eficazes se usados como "a", "b",H0Mi IicJM »e"7 "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", em condições médicas dedoença óssea de qualquer etiologia.x. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" are effective if used as "a", "b", H0Mi IicJM »and" 7 "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n ", under medical conditions bone disease of any etiology.
xi. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c" "d" "e", "f, "g", "h", "i", " j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", em condições médicas dearritmias cardíacas de qualquer etiologia.xi All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c" "d" "e", "f," g "," h "," i "," j "," k ", and" L " added to "m" or "n" or "m + n" or as any combination of any or all entries from "a" to "L" added to "m" or "n" or "m + n" under medical conditions cardiac arrhythmias of any etiology.
xii. Todos de "a", "b", "c", "d", "e", "f", "g", "h","j", "k", e "L" são eficazes se usados como "a", "b","c" "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas as entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", em condições médicas deperda de transparência das lentes dos olhos, córnea, corpovítreo ou aquoso ou perda de transparência de qualquercomponente do olho de qualquer etiologia.xii. All of "a", "b", "c", "d", "e", "f", "g", "h", "j", "k", and "L" are effective if used like "a", "b", "c" "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n ", under medical conditions transparency of the lens of the eye, cornea, body or water or loss of transparency of any eye component of any etiology.
xiii. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", em condições médicasassociadas com desenvolvimento de placas de aretoma emqualquer lugar do corpo humano ou animal de qualqueretiologia.xiii. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n ", in medical conditions associated with the development of aretoma plaques anywhere in the human or animal body of any etiology.
Xiv. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", em condições médicasassociadas com desenvolvimento das placas no sistemanervoso em qualquer lugar do corpo humano ou anila dequalquer etiologia.Xiv. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n ", in medical conditions associated with the development of plaques in the nervous system anywhere in the human body or anila of any etiology.
xv. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b",11C111 "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", em condições médicasassociadas com falhas na condução do impulso em qualquerlugar do corpo humano ou animal de qualquer etiologia.xv. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", 11C111 "d", "e", "f," g "," h "," i "," j "," k ", and" L "added a "m" or "n" or "m + n" or as any combination of any or all entries from "a" to "L" added to "m" or "n" or "m + n" under medical conditions associated with failure to conduct the impulse anywhere in the human or animal body of any etiology.
xvi. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou qualquer combinação dequalquer ou todas entradas de "a" a "L" adicionado a "m" ou"n" ou "m+n", em condições médicas associadas comnecessidade de glicuronização de qualquer e todassubstâncias necessárias para glicuronização hepática.xvi. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n ", under conditions associated with the need for glucuronization of any and all substances necessary for hepatic glucuronization.
xvi i. Todos de "a", "b", "c", "d", "e", "f", "g", "h","i", "j", "k", e "L" são eficazes se usados como "a", "b","c", "d", "e", "f, "g", "h", "i", "j", "k", e "L"adicionado a "m" ou "n" ou "m+n" ou como qualquercombinação de qualquer ou todas entradas de "a" a "L"adicionado a "m" ou "n" ou "m+n", em condições médicasassociadas com necessidade de glicuronização de qualquer etoda overdose ou intoxicação por droga em necessidade deglicuronização hepática.xvi i. All from "a", "b", "c", "d", "e", "f", "g", "h", "i", "j", "k", and "L" They are effective if used as "a", "b", "c", "d", "e", "f," g "," h "," i "," j "," k ", and" L "added to" m "or" n "or" m + n "or as any combination of any or all entries from" a "to" L "added to" m "or" n "or" m + n ", in medical conditions associated with the need for glucuronization of any overdose or drug intoxication in need of hepatic glucuronization.
Claims (2)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EG2005010036 | 2005-01-24 | ||
EG2005010036 | 2005-01-24 | ||
PCT/EG2006/000004 WO2006076927A2 (en) | 2005-01-24 | 2006-01-22 | General solvent synthesis, production and utility |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0614031A2 true BRPI0614031A2 (en) | 2011-03-01 |
Family
ID=36692595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0614031-9A BRPI0614031A2 (en) | 2005-01-24 | 2006-01-22 | manufacture, production, preparation and processing of a mixture of different combinations of anhydrous or aqueous volumes or in any molar amounts or volumes of the following soluble salts |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1851300A4 (en) |
JP (1) | JP2008528793A (en) |
KR (1) | KR20070101355A (en) |
CN (1) | CN101107350A (en) |
AP (1) | AP2007004107A0 (en) |
AU (1) | AU2006207750A1 (en) |
BR (1) | BRPI0614031A2 (en) |
CA (1) | CA2594768A1 (en) |
EA (1) | EA200701435A1 (en) |
IL (1) | IL184597A0 (en) |
MA (1) | MA29249B1 (en) |
MX (1) | MX2007008979A (en) |
NO (1) | NO20074191L (en) |
TN (1) | TNSN07271A1 (en) |
WO (1) | WO2006076927A2 (en) |
ZA (1) | ZA200706091B (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2382329A1 (en) * | 1999-09-02 | 2001-03-08 | Ricky Ah-Man Woo | Method of deodorizing and/or cleaning carpet using a composition comprising odor control agent |
JP4542279B2 (en) * | 2001-03-30 | 2010-09-08 | 株式会社ファンケル | Cleaning composition |
JP2002322491A (en) * | 2001-04-23 | 2002-11-08 | Fancl Corp | Cleansing composition |
JP4625595B2 (en) * | 2001-06-06 | 2011-02-02 | 塩水港精糖株式会社 | Skin cleanser |
US6787511B2 (en) * | 2002-08-14 | 2004-09-07 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Biphasic composition induced by polydextrose |
-
2006
- 2006-01-22 EP EP06704104A patent/EP1851300A4/en not_active Withdrawn
- 2006-01-22 AU AU2006207750A patent/AU2006207750A1/en not_active Abandoned
- 2006-01-22 CN CNA2006800030369A patent/CN101107350A/en active Pending
- 2006-01-22 EA EA200701435A patent/EA200701435A1/en unknown
- 2006-01-22 AP AP2007004107A patent/AP2007004107A0/en unknown
- 2006-01-22 JP JP2007555455A patent/JP2008528793A/en active Pending
- 2006-01-22 KR KR1020077019496A patent/KR20070101355A/en not_active Application Discontinuation
- 2006-01-22 WO PCT/EG2006/000004 patent/WO2006076927A2/en active Application Filing
- 2006-01-22 CA CA002594768A patent/CA2594768A1/en not_active Abandoned
- 2006-01-22 MX MX2007008979A patent/MX2007008979A/en unknown
- 2006-01-22 BR BRPI0614031-9A patent/BRPI0614031A2/en not_active IP Right Cessation
-
2007
- 2007-07-12 IL IL184597A patent/IL184597A0/en unknown
- 2007-07-13 TN TNP2007000271A patent/TNSN07271A1/en unknown
- 2007-07-23 ZA ZA200706091A patent/ZA200706091B/en unknown
- 2007-08-13 MA MA30135A patent/MA29249B1/en unknown
- 2007-08-15 NO NO20074191A patent/NO20074191L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1851300A4 (en) | 2010-04-14 |
KR20070101355A (en) | 2007-10-16 |
EA200701435A1 (en) | 2008-10-30 |
JP2008528793A (en) | 2008-07-31 |
MA29249B1 (en) | 2008-02-01 |
CA2594768A1 (en) | 2006-07-27 |
NO20074191L (en) | 2007-08-15 |
MX2007008979A (en) | 2007-09-21 |
AP2007004107A0 (en) | 2007-08-31 |
IL184597A0 (en) | 2007-10-31 |
CN101107350A (en) | 2008-01-16 |
EP1851300A2 (en) | 2007-11-07 |
AU2006207750A1 (en) | 2006-07-27 |
TNSN07271A1 (en) | 2008-12-31 |
WO2006076927A2 (en) | 2006-07-27 |
ZA200706091B (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gilman et al. | Clinical uses of 2, 3-dimercaptopropanol (BAL). X. The treatment of acute systemic mercury poisoning in experimental animals with BAL, thiosorbitol and BAL glucoside | |
JP2005522433A5 (en) | ||
FIU20060390U0 (en) | Use of rare earth alkaline metal compounds for the prevention of kidney stone disease | |
BRPI0614031A2 (en) | manufacture, production, preparation and processing of a mixture of different combinations of anhydrous or aqueous volumes or in any molar amounts or volumes of the following soluble salts | |
KR880012642A (en) | Crystalline human proinsulin and its preparation method | |
JPS5792520A (en) | Preparation of spherical calcium carbonate | |
Potter et al. | The determination of ammonia in soils | |
SU488395A3 (en) | The method of purification of aqueous solutions of ions of polyvalent metals | |
US3019183A (en) | Method of softening water by ion exchange | |
Mellanby | The rate of formation of fibrin ferment from prothrombin by the action of thrombokinase and calcium chloride | |
Daniels | The influence of lithium and atophan on the uric acid excretion of a gouty patient | |
JPS5678680A (en) | Treatment for water containing fluoride ion | |
CN1229071A (en) | Water-soluble heparin type chitosan sulfanilamide anticoagulation agent | |
RU2108303C1 (en) | Composition for removing iron sulfide deposits | |
JPS5533499A (en) | N2-arylsulfonyl-l-arginineamide and its pharmaceutically acceptable salt | |
Grases et al. | Evolution of post-ESWL residual lithiasis depending on the type of calculus and urine composition | |
SU991032A1 (en) | Composition for removing gypsum deposits | |
SU1041178A1 (en) | Apparatus for cleaning pipeline interior surfaces | |
SU1263655A1 (en) | Compound for preventing deposition of salts in oil field equipment | |
SU1116024A1 (en) | Composition for stabilization processing of aqueous solutions | |
DE420910C (en) | Process for the preparation of double compounds from aliphatic amino acids and inorganic alkali salts | |
Rozkin et al. | Study of the mechanism of the anticoagulant action of fucoidans | |
SU563423A1 (en) | Method of producing water-insoluble flocculating biopolymers from active silt | |
TH42674A (en) | Method for cleaning the sugar solution | |
Isaev et al. | REGENERATION OF ACID WASTES FROM WATER DESALTING EQUIPMENT BY AN ELECTROCHEMICAL METHOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |